Metro Chicago – October 01, 2026 -- Calamos Investments has declared monthly distributions paid in October 2026 across seven of its closed-end funds, accompanied by mandatory source-of-distribution disclosures required under Section 19 of the Investment Company Act of 1940.

Westminster, Colo. – October 01, 2026 -- The Centers for Medicare & Medicaid Services has granted New Technology Add-On Payment status to Cerapedics Inc.'s PearlMatrix P-15 Peptide Enhanced Bone Graft, enabling hospitals to recoup up to 65% of the additional cost tied to the device starting October 1, 2026.

Farmington Hills – October 01, 2026 -- Coretek has achieved ISO/IEC 42001 certification, becoming among the first organizations globally to earn the world's first international standard for Artificial Intelligence Management Systems (AIMS).

Oakland, Calif. – October 01, 2026 -- Pacific Gas and Electric Company (PG&E) has filed a proposed 10-Year Electrical Undergrounding Plan (EUP) with the California Office of Energy Infrastructure Safety, projecting $117 billion in long-term benefits from burying 5,000 miles of distribution lines across more than 30 Northern and Central California counties between 2028 and 2037.

Boston – October 01, 2026 -- HoneyNaps, an AI-based sleep health technology company, has completed registration as a clinical research organization (CRO) with South Korea's National Enterprise for Clinical Trials (KoNECT), broadening its role in pharmaceutical and medical device trials worldwide.

Dallas – October 01, 2026 -- Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted and granted priority review to Nanoscope Therapeutics' New Drug Application for MOGENRY (sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy for inherited retinal dystrophies (IRDs). If approved by the Ministry of Health, Labour and Welfare, MOGENRY would become the first disease-agnostic treatment available to IRD patients in Japan, a condition caused by mutations across more than 250 genes that leads to progressive photoreceptor loss and blindness.

Courbevoie – October 01, 2026 -- ACI EUROPE, Amadeus, IATA, IDEMIA Public Security and SITA have formed the Responsible Biometrics Travel Industry Coalition, pressing EU policymakers to prevent the bloc's Digital Omnibus legislation from restricting voluntary biometric use in air travel.

The five organizations argue the current legislative proposal, designed to simplify Europe's digital rulebook and strengthen competitiveness, could unintentionally curb passengers' ability to opt into biometric verification at airports.

Los Angeles – September 30, 2026 -- Langar Investment Management, LLC will liquidate and close the Langar Global HealthTech ETF (Ticker: LGHT), a series of the Spinnaker ETF Series, after the Trust's Board of Trustees approved a Plan of Liquidation and Termination.

Chennai – – September 30, 2026 -- MPS Limited said its Artificial Intelligence Management System has been certified to ISO/IEC 42001:2023, the first international standard for AI management systems, following a multi-stage external audit by DNV Business Assurance.

Secaucus, N.J. – September 30, 2026 -- Pierre Fabre Pharmaceuticals Inc. (PFP) has resubmitted a Biologics License Application to the U.S. Food and Drug Administration for tabelecleucel, seeking approval as a monotherapy for adult and pediatric patients aged 2 and older with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed at least one prior therapy.